These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
230 related articles for article (PubMed ID: 15584766)
1. The role of stimulants in the treatment of preschool children with attention-deficit hyperactivity disorder. Kratochvil CJ; Greenhill LL; March JS; Burke WJ; Vaughan BS CNS Drugs; 2004; 18(14):957-66. PubMed ID: 15584766 [TBL] [Abstract][Full Text] [Related]
2. A process for developing community consensus regarding the diagnosis and management of attention-deficit/hyperactivity disorder. Foy JM; Earls MF Pediatrics; 2005 Jan; 115(1):e97-104. PubMed ID: 15629972 [TBL] [Abstract][Full Text] [Related]
3. Prevalence of prescribed attention-deficit hyperactivity disorder medications and diagnosis among Canadian preschoolers and school-age children: 1994-2007. Brault MC; Lacourse É Can J Psychiatry; 2012 Feb; 57(2):93-101. PubMed ID: 22340149 [TBL] [Abstract][Full Text] [Related]
4. Treatment of attention-deficit/hyperactivity disorder: overview of the evidence. Brown RT; Amler RW; Freeman WS; Perrin JM; Stein MT; Feldman HM; Pierce K; Wolraich ML; ; Pediatrics; 2005 Jun; 115(6):e749-57. PubMed ID: 15930203 [TBL] [Abstract][Full Text] [Related]
5. Diagnosis and treatment of attention deficit hyperactivity disorder (ADHD). NIH Consens Statement; 1998 Nov 16-18; 16(2):1-37. PubMed ID: 10868163 [TBL] [Abstract][Full Text] [Related]
6. Beyond the 'typical' patient: treating attention-deficit/hyperactivity disorder in preschoolers and adults. Vaughan BS; Wetzel MW; Kratochvil CJ Int Rev Psychiatry; 2008 Apr; 20(2):143-9. PubMed ID: 18386204 [TBL] [Abstract][Full Text] [Related]
7. Cessation of attention deficit hyperactivity disorder drugs in the young (CADDY)--a pharmacoepidemiological and qualitative study. Wong IC; Asherson P; Bilbow A; Clifford S; Coghill D; DeSoysa R; Hollis C; McCarthy S; Murray M; Planner C; Potts L; Sayal K; Taylor E Health Technol Assess; 2009 Oct; 13(50):iii-iv, ix-xi, 1-120. PubMed ID: 19883527 [TBL] [Abstract][Full Text] [Related]
8. Physician Office Visits for Attention-deficit/Hyperactivity Disorder in Children and Adolescents Aged 4-17 Years: United States, 2012-2013. Albert M; Rui P; Ashman JJ NCHS Data Brief; 2017 Jan; (269):1-8. PubMed ID: 28135186 [TBL] [Abstract][Full Text] [Related]
9. Clinical diagnosis and management of attention deficit hyperactivity disorder in preschool children. Kaplan A; Adesman A Curr Opin Pediatr; 2011 Dec; 23(6):684-92. PubMed ID: 22045309 [TBL] [Abstract][Full Text] [Related]
10. Pharmacotherapy for incident attention-deficit/hyperactivity disorder: practice patterns and quality metrics. Bussing R; Narwaney KJ; Winterstein AG; Newton DA; DeBar L; Boscarino JA; Toh S; Pawloski P; Nordin JD; Herrinton LJ; Mason D; Daley MF Curr Med Res Opin; 2014 Aug; 30(8):1687-99. PubMed ID: 24635013 [TBL] [Abstract][Full Text] [Related]
12. Attention deficit hyperactivity disorder in preschool children. Greenhill LL; Posner K; Vaughan BS; Kratochvil CJ Child Adolesc Psychiatr Clin N Am; 2008 Apr; 17(2):347-66, ix. PubMed ID: 18295150 [TBL] [Abstract][Full Text] [Related]
13. Impact of comorbid autism spectrum disorders on stimulant response in children with attention deficit hyperactivity disorder: a retrospective and prospective effectiveness study. Santosh PJ; Baird G; Pityaratstian N; Tavare E; Gringras P Child Care Health Dev; 2006 Sep; 32(5):575-83. PubMed ID: 16919137 [TBL] [Abstract][Full Text] [Related]
14. Pharmacologic intervention for attention-deficit hyperactivity disorder in preschoolers : is it justified? Ghuman JK; Ghuman HS Paediatr Drugs; 2013 Feb; 15(1):1-8. PubMed ID: 23329386 [TBL] [Abstract][Full Text] [Related]
17. Medicaid Prior Authorization Policies for Medication Treatment of Attention-Deficit/Hyperactivity Disorder in Young Children, United States, 2015. Hulkower RL; Kelley M; Cloud LK; Visser SN Public Health Rep; 2017; 132(6):654-659. PubMed ID: 29072963 [TBL] [Abstract][Full Text] [Related]
18. Preschool attention deficit hyperactivity disorder: a review of prevalence, diagnosis, neurobiology, and stimulant treatment. Connor DF J Dev Behav Pediatr; 2002 Feb; 23(1 Suppl):S1-9. PubMed ID: 11875284 [TBL] [Abstract][Full Text] [Related]
19. The evidence-based pharmacological treatment of paediatric ADHD. Vaughan BS; March JS; Kratochvil CJ Int J Neuropsychopharmacol; 2012 Feb; 15(1):27-39. PubMed ID: 21329553 [TBL] [Abstract][Full Text] [Related]
20. Common Use of Stimulants and Alpha-2 Agonists to Treat Preschool Attention-Deficit Hyperactivity Disorder: A DBPNet Study. Blum NJ; Shults J; Harstad E; Wiley S; Augustyn M; Meinzen-Derr JK; Wolraich ML; Barbaresi WJ J Dev Behav Pediatr; 2018 Sep; 39(7):531-537. PubMed ID: 29851669 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]